Glucocorticoids exacerbate the deleterious effects of gp120 in hippocampal and cortical explants

Journal of Neurochemistry

Volumn 74, Issue 3, 2000, Pages 1000-1007

  Yusim, Anna ^a   Franklin, Laura ^a   Brooke, Sheila ^a   Ajilore, Olusola ^a   Sapolsky, Robert ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Cortical explant; Glucocorticoids; Glycoprotein gp120; Hippocampal explant; Human immunodeficiency virus

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; CORTICOSTEROID; GLUCOCORTICOID; GLYCOPROTEIN GP 120; PREDNISONE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM MOBILIZATION; CONTROLLED STUDY; EXPLANT; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METABOLIC RATE; MONOLAYER CULTURE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STRESS;

ADRENALECTOMY; ANIMALS; CALCIUM; CEREBRAL CORTEX; CORTICOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; HIPPOCAMPUS; HIV ENVELOPE PROTEIN GP120; MALE; OSMOLAR CONCENTRATION; PREDNISONE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0033962590     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0741000.x     Document Type: Article

References (36)

1. Ajilore O. A. and Sapolsky R. M. (1997) Application of silicon microphysiometry to tissue slices: detection of metabolic correlates of selective vulnerability. Brain Res. 752, 99-106.
2. Barks J. and Liu S. (1997) gp120, a human immunodeficiency virus-1 coat protein, augments excitotoxic hippocampal injury in perinatal rats. Neuroscience 76, 397-405.
3. Barks J., Sun R., Malinak C., and Silverstein F. (1995) gp120, an HIV-1 protein, increases susceptibility to hypoglycemic and ischemic brain injury in perinatal rats. Exp. Neurol. 132, 123-133.
4. Beal M. (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119-130.
5. Brooke S. M., Trafton J. A., and Sapolsky R. M. (1996) Autofluorescence as a confound in the determination of calcium levels in hippocampal slices using fura-2AM dye. Brain Res. 706, 283-290.
6. Brooke S. M., Chan R., Howard S. A., and Sapolsky R. M. (1997) Endocrine modulation of the neurotoxicity of gp120: implications for AIDS-related dementia complex. Proc. Natl. Acad. Sci. USA 94, 9457-9462.
7. Brooke S. M., Howard S. A., and Sapolsky R. M. (1998) Energy dependency of glucocorticoid exacerbation of gp120 neurotoxicity. J. Neurochem. 71, 1187-1193.
8. Doyle P., Rohner-Jeanrenaud F., and Jeanrenaud B. (1994) Alterations of local cerebral glucose utilization in lean and obese fa/fa rats after acute adrenalectomy. Brain Res. 655, 115-120.
9. Dreyer E., Kaiser P., Offermann J., and Lipton S. (1990) HIV-1 coat protein neurotoxicity prevented by calcium channel antagonists. Science 248, 364-367.
10. Freo U., Holloway H., Kalogeras K., Rapoport S. I., and Soncrant T. T. (1992) Adrenalectomy or metyrapone-pretreatment abolishes cerebral metabolic responses to the serotonin agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) in the hippocampus. Brain Res. 586, 256-264.
11. Gagnon S., Boota A., Fischl M., Baier H., Kirksey O., and La Voie L. (1990) Corticosteroids as adjunctive therapy for severe Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A double-blind, placebo-controlled trial. N. Engl. J. Med. 323, 1444-1450.
12. Gendelman H., Lipton S., Tardieu M., Bukrinsky M., and Nottet H. (1994) The neuropathogenesis of HIV-1 infection. J. Leukoc. Biol. 56, 389-398.
13. Giulian D., Yu J., Li X., Tom D., Li J., Wendt E., Lin S., Schwarcz R., and Noonan C. (1996) Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J. Neurosci. 16, 3139-3153.
14. Horner H. C., Packan D. R., and Sapolsky R. M. (1990) Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 52, 57-62.
15. Howard S. A., Nakayama A. Y., Brooke S. M., and Sapolsky R. M. (1999) Glucocorticoid modulation of gp120-induced effects on calcium-dependent degenerative events in primary hippocampal and cortical cultures. Exp. Neurol. 158, 164-170.
16. Iyer A., Brooke S., and Sapolsky R. (1998) Glucocorticoids interact with gp120 in causing neurotoxicity in striatal cultures. Brain Res. 808, 305-309.
17. Kadekaro M., Masanori I., and Gross P. (1988) Local cerebral glucose utilization is increased in acutely adrenalectomized rats. Neuroendocrinology 47, 329-337.
18. Kimes A. S., London E. D., Szabo G., Raymon L., and Tabakoff B. (1991) Reduction of cerebral glucose utilization by the HIV envelope glycoprotein gp-120. Exp. Neurol. 112, 224-228.
19. Lavi E., Kolson D. L., Ulrich A. M., Fu L., and Gonzalez-Scarano F. (1998) Chemokine receptors in the human brain and their relationship to HIV infection. J. Neurovirol. 4, 301-311.
20. Lawrence M. S. and Sapolsky R. M. (1994) Glucocorticoids accelerate ATP loss following metabolic insults in cultured hippocampal neurons. Brain Res. 646, 303-306.
21. Limoges J., Persidsky Y., Bock P., and Gendelman H. (1997) Dexamethasone therapy worsens the neuropathology of human immunodeficiency virus type 1 encephalitis in SCID mice. J. Infect. Dis. 175, 1368-1381.
22. Lipton S. (1998) Neuronal injury associated with HIV-1: approaches to treatment. Annu. Rev. Pharmacol. Toxicol. 38, 159-177.
23. Luthert P., Montgomery M., Dean A., Cook R., Baskerville A., and Lantos P. (1995) Hippocampal neuronal atrophy occurs in rhesus macaques following infection with simian immunodeficiency virus. Neuropathol. Appl. Neurobiol. 21, 529-534.
24. Masliah E., Ge N., Morey M., DeTeresa R., Terry R., and Wiley C. (1992a) Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab. Invest. 66, 285-291.
25. Masliah E., Ge N., Achim C., Hansen L., and Wiley C. (1992b) Selective neuronal vulnerability in HIV encephalitis. J. Neuropathol. Exp. Neurol. 51, 585-593.
26. Masliah E., Ge N., and Mucke L. (1996) Pathogenesis of HIV-1 associated neurodegeneration. Crit. Rev. Neurobiol. 10, 57-67.
27. McConnell H. M., Owicki J. C., Parce J. W., Miller D. L., Baxter G. T., Wada H. G., and Pitchford S. (1992) The cytosensor microphysiometer: biological applications of silicon technology. Science 257, 1906-1912.
28. McEwen B., de Kloet E., and Rostene W. (1986) Adrenal steroid receptors and actions in the nervous system. Physiol. Rev. 66, 1121-1163.
29. Raley-Susman K. M., Miller K. R., Owicki J. C., and Sapolsky R. M. (1992) Effects of excitotoxin exposure on metabolic rate of primary hippocampal cultures: application of silicon microphysiometry to neurobiology. J. Neurosci. 12, 773-780.
30. Sapolsky R. M. (1996) Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1, 1-19.
31. Sapolsky R., Brooke S., and Stein-Behrens B. (1995) Methodologic issues in studying glucocorticoid-induced damage to neurons. J. Neurosci. Methods 58, 1-15.
32. Toggas S., Masliah E., Rockenstein F., Rall G., Abraham C., and Mucke L. (1994) Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature 367, 188-193.
33. Tombaugh G. C. and Sapolsky R. M. (1992) Corticosterone accelerates hypoxia- and cyanide-induced ATP loss in cultured hippocampal astrocytes. Brain Res. 588, 154-158.
34. Trafton J., Tombaugh G., Yang S., and Sapolsky R. (1996) Salutary and deleterious effects of acidity on an indirect measure of metabolic rate and ATP concentrations in CNS cultures. Brain Res. 731, 122-131.
35. Turski L. and Turski W. (1993) Toward an understanding of the role of glutamate in neurodegenerative disorders: energy metabolism and neuropathology. Experientia 49, 1064-1072.
36. Virgin C. E. Jr., Ha T. P., Packan D. R., Tombaugh G. C., Yang S. H., Horner H. C., and Sapolsky R. M. (1991) Glucocorticoids inhibit glucose transport and glutamate uptake in hippocampal astrocytes: implications for glucocorticoid neurotoxicity. J. Neurochem. 57, 1422-1428.